· AIM:Toevaluatetheefficacyandsafetyofglaucoma drainagedeviceEx-PRESS誖 P-50forcombinedcataract surgeryandglaucoma.
· RESULTS:Outof40eyesof40patients(55%maleand 45%female)completedthestudyduringone-year follow-up.Themeanofagewas76.6 依11.02y.The intraocularpressure(IOP)decreasedsignificantlyduring the12-monthfollow-upfrom23.5mmHgto16.8mmHg (Wilcoxonsignedrankstest, <0.001).A59.5%of patientsdidnotneedanytopicaltreatment,10.8%of themneededoneactiveprinciple,27%neededtwoactive principles, and 2.7% of them needed three active principlesforsuccessfulIOPcontrol(<21mmHg).
· CONCLUSION:Combinedsurgeryofphacoemulsification withExPRESS 誖 P-50lowersIOPfromthepreoperative baseline and reduces significantly the number of antiglaucomaactiveprinciplesforIOPcontrolafterthe operation.
INTRODUCTION
C ataractandglaucomausuallyaffectelderlypopulation. Bothpathologiesarestronglyrelatedtotheaging processandmayfrequentlyaffectthesameindividual patient.Besidesage,thismightberelatedtothepossiblerole ofantiglaucomamedicationsintheprogressionoflens opacity [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] .Glaucomafilteringsurgeryisindicatedwhen glaucomatousdamageprogressesdespitethelowerlevelof intraocularpressure (IOP)obtainedwithpharmacological treatment. Itisalso requiredwhenmaximun antiglaucomatousmedicationsareinsufficienttodecrease IOPtotargetedlevels [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] .Whencataractsurgeryand glaucomasurgeryarerequired,thesecanbeperformed separatelyorincombination.Trabeculectomyhasbeenthe gold-standardtreatmentforprimaryopenangleglaucoma (POAG)since1968 [1] .However,thetube-shuntoperations maybeequallyeffectiveincontrollingPOAG [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] .While full-thicknessfiltrationproceduresconsiderablyreducedthe IOP,theywereassociatedwithearlypostoperativehypotony andrelatedsideeffectsandbecameprogressivelyless popular.Glaucomadrainageimplants,designedtoshuntthe aqueousposteriorly,representanalternativemethodfor loweringIOPinglaucomatouspatients [2] [3] [4] [5] [6] [7] [8] .TheExPRESS ® glaucomafiltrationdevice(Alcon,FortWorth,Texas,USA) isastainlesssteelminiatureglaucomadevice,developedas analternativetotrabeculectomyforpatientswithPOAG. Thisprocedurewouldbetheoreticallymorereproducibleand simpletoperformaswellaslesstraumatictotheocular tissuethantraditionalfilteringsurgery.Althoughthestandard trabeculectomyisstillthemostcommonlyusedglaucoma operationworldwide,the Ex-PRESSexhibitssimilar outcomeswithfewerearlypostoperativecomplications [2] [3] [4] [5] .It wasinitiallyinsertedfromthelimbusintotheanterior chamberandplacedunderneaththeconjunctiva,thecurrently adoptedmethodplacesitunderthescleralflaptoavoid overfiltration, exposureofthe Ex-PRESS,andother complications [6] [7] [8] [9] .Thisshuntprocedurecanbeperformedon itsownorincombinationwith cataract surgeryby phacoemulsification [2] . Thecombinedcataractsurgerybyphacoemulsificationand trabeculectomyhasbeensuccessfullyperformed [10] .This combinedprocedureenablestolowertheIOPandgainin visualacuityinonesurgery,withthetreatmentoftwo [10] .Combinedsurgeryforcataractand glaucomaisassociatedwithlesslong-termIOPreduction comparedwith trabeculectomy alone.Nevertheless, combinedsurgeryeffectivelylowersIOPandreducesthe long-termrequirementforantiglaucomamedicationswithout additionalcomplications [11] .However,theearlypostoperative hypotonyandrelated sideeffects,suchas choroidal detachment,athalamiaandpharmacologicmidriasisby cycloplegicagents,causeslowervisualrecovery.The emergenceofnewdevicesinglaucomafilteringsurgerymay contributethesecomplicationstobe lessfrequentin combinedcataractandglaucomasurgery [12] [13] .TheEx-PRESS ® glaucomafiltrationdeviceisaminiaturestainlesssteel glaucomadevice, developedasanalternativeto trabeculectomyandtotheothertypesofglaucomafiltering surgeryforpatientswithPOAG.TheEx-PRESS ® R-50 devicehasbeensuccessfullyemployedtoincreaseoutflowin glaucomapatients [2, [4] [5] .Somestudieshaveshownthat phacoemulsificationplusEx-PRESS ® R-50implantationare significantlymoreeffectiveinreducingIOPandmedication usethanphacoemulsificationalone [6, 14] .Asecondgeneration Ex-PRESS ® P-50hasrecentlybeendeveloped.Tothebestof ourknowledge,theefficacyandsafetyofthenewEx-PRESS ® P-50devicehaveonlybeenevaluatedinglaucomafiltering surgery [15] [16] [2, 17] .TheEx-PRESSglaucoma filtrationdevicewasdesignedtodrainaqueousfluidfromthe anteriorchambertothesubconjunctivalspace,forminga filtrationbleb,akintoatrabeculectomy.Itwascurrently availableintwomodels:R-modelandP-model.The Ex-PRESSR-modelhasabeveledtip,anexternaldiameter of400 滋m(27-gauge),aninternallumenof50 滋m,atotal devicelengthof2.96mmandauniformbackplate.The Ex-PRESS ® P-50modelhasadecreasedbevelangle,an externaldiameterof400 滋m,atotaldevicelengthof 2.64mmandaverticalchannelbackplate.Itisavailablein botha50-滋mand200-滋minternallumensize [17] .The P-modelfeaturesverticalchannelsintheplate,designedto enhanceposteriorflowofaqueousandformationofamore diffuseposteriorbleb.Thedevicesalsocontainareliefport designedtoprovideanalternativepathwayforaqueous shouldtheaxiallumenbecomeoccludedbyiris,fibrinor blood [16] .Fourstudieshavepublishedresultsofthe Ex-PRESS ® R-50implantcombinedwithphacoemulsification cataractextraction,twoofthemunderconjuntivalflap [6, 14] and theotheronesunderscleralflap [2, 18] .Thus,Traverso [14] included26eyesof25patients.Theoverallsuccessrate(IOP 臆21mmHg),withorwithoutmedications,was94.4%at twoyears.Seriouscomplicationsasconjunctivalerosion werereportedinthreecases(11.5%).Themainlimitationof thisstudywastherelativelysmallnumberofpatients. However,itsstrengthswerethelengthoffollow-upand excellentIOPcontrol.ThesecondtrialoftheEx-PRESS ® R-50shuntunderconjunctivalflapcombinedwithcataract extractionwasimplantedin35eyesof35patientswhowere followedforupto48mo [6] .Conjunctivalerosionwasreported infourcases(11.4%).Tenpatients (32.7%)remained withoutmedicatonsafterthefollow-up.Thestudyshowed that, despiteagoodIOP control,Ex-PRESS ® R-50 implantationundertheconjunctivawasassociatedwitha relativelyhighnumberof complications. Theauthors concludedthatarefinement inthetubedesign and implantationtechniquewouldincreasethesuccessrate. Maris [2] implantedunderscleralflaptheEx-PRESS ® R-50devicecombinedwith phacoemulsificationina subgroupof15patientsofacomparativeseriesbetween trabeculectomyandEx-PRESS ® R-50implant.Overall surgicalsuccesswasnotdifferentineyestreatedwith combinedsurgerycomparedwiththosetreatedonlywiththe Ex-PRESSdevice. Nospecial complicationsforthis subgroupwerereported.Thelimitationsofthisstudywere thesmallsubgroupofcombinedsurgeryandafollow-upof 10.8months.Kanner [18] reported231eyestreatedwith ExPRESS ® R-50aloneand114eyesoperatedwithExPRESS ® R-50filteringsurgeryandphacoemulsificationwitha follow-upof21.9mo.Comparedwithbaselinevalues,the IOPandnumberofglaucomamedicationsweresignificantly loweredinbothgrops.However,thechangeofIOPfrom baselinewasloweraftertheExPRESS ® R-50implantalone. Presentstudyisevidentlythefirstreportofmid-term postoperativeresultsincombinedsurgerywiththeEx-PRESS ® P-50deviceunderscleralflap.Oursuccessratewassimilar toTraverso [14] articleandbetterthanRivier [6] study.Kanner [18] didnotobserveinthecombinedgroup ofphacoemulsificationandcataratwiththeR-50model. Nevertheless,thesamestudyreportedconjunctivalerosionin 0.43%ofcaseswiththeEx-PRESS ® R-50devicealone withoutphacoemulsification.ThemostcommondevicerelatedcomplicationdescribedbyKanner [18] was blockageofthelumenoftheimplant,whichwaseffectively treatedwithNd:Yaglaser.Thecausesofocclusionwerethe presenceofpigmentorvitreousinthelumen.Wedidnot observethiscomplication.Itmaybebecausewehadno patientswithanycomplicationduringtheoperation,suchas capsularbagfailureandvitreousloss.Inthefirstweek, Kanner [18] reporteda7.9%ofhypotonycases.We observedthiscomplicationinonly5%ofcases,whichisnot reallysignificant.Twocasesofourseriesneededsuturelysis (5%)forloweringtheIOPaftertheprocedure. InourstudytheBCVAsignificantlyincreased.This improvementisadirectbenefitofcataractsurgeryasin previousreports [6, 14] .Nohighimprovementofthevisualacuity occurredinourserieduetotheadvancedstageoftheglaucoma. Nevertheless,theadditionalIOPreductionassociatedto cataractsurgerymaycontributetothemaintenanceofBCVA duringthe12-monthfollow-up.IOPsignificantlydecreased frompreoperativebaselinevaluesinallfollow-upexams. Regardingthesuccessrate,57.5%ofpatientsdidnotneed additionalantiglaucomamedicationsandthepercentageof patientswhichreducedthenumberoftopicalmedications wasalsosignificant.Thisfactisinaccordancewithprevious studies [6, [13] [14] 18] .IfwetakeassuccessanIOP 臆21mmHg,we obtaineda92.5%ofsuccess.59.5%ofthemdidnot needanytreatmentand40.5%ofthemneededtopical treatmentforIOPcontrol.Oursuccessrateof92.5%would beinagreementwiththesuccessratereportedinthe literature,whichisapproximately60%-100%forthe trabeculectomy [8, [19] [20] . Althoughthepercentageofsuccessmaybedecresasedafter thefirstyearoftheimplantationoftheEx-PRESS ® P-50 device, similarrateshavebeendescribedfollowing trabeculectomy [4] .Manytrabeculectomiesstartfailinginthe secondyearasdoEx-PRESSshuntimplantations [11] .Themain riskfactorsforfailureoftheEx-PRESSdevicearediabetes, non-Caucasianrace,andpreviousglaucomasurgery [4] . Theadvantageagainsttrabeculectomyisthatthereisno iridectomyandnosclerectomyduringtheimplantationofthe Ex-PRESSdevice.Thus,thepostoperativeinflammationand anteriorchamberreactionmaybesimilartothe phacoemulsificationaloneincasesofcombinedsurgerywith theadvantagethatitispossibletodiminishadditionallythe IOP.InthepostoperativeperiodtheEx-PRESSdevicedonot needadditionaltreatmentwithcycloplegicagents.Thisfact makesmorerapidthevisualrecovery.Someofthese advantagesmakeitsuseinspecialcasesaspatientswithonly oneusefuleye [21] . ThecriticismtotheuseofEx-PRESSisthesignificant increasedcostofthesurgery [22] .However,recentpublished studiesconcludethatvisualrecoveryismorerapidwiththe Ex-PRESSdevicethantrabeculectomy [5] .Furthermore,the IOPvariationwaslowerduringtheearlypostoperative period,andpostoperativecomplicationswerelessfrequent afterEx-PRESimplantationcomparedwiththeclassic trabeculectomy.Theseresultsaddedtothecaratactsurgery haveanimportantadvantageforamorerapidvisual recovery.Aswehavedemonstratedinourstudythe combinedphacoemulsificationwithEx-PRESS ® P-50hasa fewearlycomplications,improvessignificantlyBCVA, reducessignificantlytheIOPfrompreoperativebaseline valuesandalsoreducesthenumberofantiglaucomaactive principleswhicharenecessariesforIOPcontrol.Allofthis maybecosteffectiveinthecasesaffectedofcataractand glaucoma. Thelimitationofthisstudymaybethenumberofcases; nevertheless,itissimilarorevenhigherthanotherstudies [6, [13] [14] . Thelackofacontrolgroupinwhichonlycataractsurgery performedmaybeconsideredasalimitationsincecataract surgeryalonehasanimpactinIOPcontrolinsuch population [23] .Allofourpatientswerecaucasiansand,unlike otherstudies [14] ,therewasnoracialinfluenceinthe successfulrateoutcomes.Tothebestofourknowledge,this isthefirststudyofcombinedphacoemulsificationwith Ex-PRESS ® P-50. Inconclusion,thecombinedsurgeryofphacoemulsification withtheEx-PRESS ® P-50modelhasfewearlypostoperative complications,improvessignificantlytheBCVA,lowering IOPfromthepreoperativebaselinevaluesandreducingthe numberofantiglaucomaactiveprinciplesaftertheoperation.
